Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/01/15 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 06/01/15 | 8-K | Current report filing |
|
4 | |
| 05/21/15 | 8-K | Current report filing |
|
13 | |
| 05/20/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
46 |
| 05/15/15 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
4 | |
| 05/14/15 | UPLOAD | SEC-generated letter |
|
2 | |
| 04/30/15 | 8-K | Current report filing |
|
4 | |
| 04/30/15 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
25 | |
| 04/27/15 | S-3 | Registration statement for specified transactions by certain issuers |
|
89 | |
| 04/15/15 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
116 |
